Literature DB >> 15077159

Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling.

Michael D Taylor1, Xiaoyun Zhang, Ling Liu, Chi-Chung Hui, Todd G Mainprize, Stephen W Scherer, Brandon Wainwright, David Hogg, James T Rutka.   

Abstract

Germline mutations of APC in patients with Turcot syndrome (colon cancer and medulloblastoma), was well as somatic mutations of APC, beta-catenin, and Axin in sporadic medulloblastomas (MBs) have shown the importance of WNT signaling in the pathogenesis of MB. A subset of children with MB have germline mutations of SUFU, a known inhibitor of Hedgehog signal transduction. A recent report suggested that murine Sufu can bind beta-catenin, export it from the nucleus, and thereby repress beta-catenin/T-cell factor (Tcf)-mediated transcription. We show that an MB-derived mutant of SUFU has lost the ability to decrease nuclear levels of beta-catenin, and cannot inhibit beta-catenin/Tcf-mediated transcription as compared to wild type SUFU. Our results suggest that loss of function of SUFU results in overactivity of both the Sonic Hedgehog, and the WNT signaling pathways, leading to excessive proliferation and failure to differentiate resulting in MB.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15077159     DOI: 10.1038/sj.onc.1207605

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  Sox10 directs neural stem cells toward the oligodendrocyte lineage by decreasing Suppressor of Fused expression.

Authors:  Christine D Pozniak; Abraham J Langseth; Gerrit J P Dijkgraaf; Youngshik Choe; Zena Werb; Samuel J Pleasure
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

Review 2.  Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies.

Authors:  Mandeep S Tamber; Krishan Bansal; Muh-Lii Liang; Todd G Mainprize; Bodour Salhia; Paul Northcott; Michael Taylor; James T Rutka
Journal:  Childs Nerv Syst       Date:  2006-09-02       Impact factor: 1.475

Review 3.  Emerging treatments and gene expression profiling in high-risk medulloblastoma.

Authors:  Iacopo Sardi; Duccio Cavalieri; Maura Massimino
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

4.  PCDH10 is a candidate tumour suppressor gene in medulloblastoma.

Authors:  Kelsey C Bertrand; Stephen C Mack; Paul A Northcott; Livia Garzia; Adrian Dubuc; Stefan M Pfister; James T Rutka; William A Weiss; Michael D Taylor
Journal:  Childs Nerv Syst       Date:  2011-05-20       Impact factor: 1.475

5.  MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression.

Authors:  Daniel Y Lee; Zhaoqun Deng; Chia-Hui Wang; Burton B Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

6.  Interaction between the TP63 and SHH pathways is an important determinant of epidermal homeostasis.

Authors:  N S Chari; R A Romano; M I Koster; V Jaks; D Roop; E R Flores; S Teglund; S Sinha; W Gruber; F Aberger; L J Medeiros; R Toftgard; T J McDonnell
Journal:  Cell Death Differ       Date:  2013-05-17       Impact factor: 15.828

Review 7.  The molecular genetics of medulloblastoma: an assessment of new therapeutic targets.

Authors:  Carlos G Carlotti; Christian Smith; James T Rutka
Journal:  Neurosurg Rev       Date:  2008-06-12       Impact factor: 3.042

Review 8.  The prenatal origins of cancer.

Authors:  Glenn M Marshall; Daniel R Carter; Belamy B Cheung; Tao Liu; Marion K Mateos; Justin G Meyerowitz; William A Weiss
Journal:  Nat Rev Cancer       Date:  2014-03-06       Impact factor: 60.716

9.  Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma.

Authors:  Yukiko Nakahara; Paul A Northcott; Meihua Li; Paul N Kongkham; Christian Smith; Hai Yan; Sidney Croul; Young-Shin Ra; Charles Eberhart; Annie Huang; Darell Bigner; Wesia Grajkowska; Timothy Van Meter; James T Rutka; Michael D Taylor
Journal:  Neoplasia       Date:  2010-01       Impact factor: 5.715

Review 10.  The clinical implications of medulloblastoma subgroups.

Authors:  Paul A Northcott; Andrey Korshunov; Stefan M Pfister; Michael D Taylor
Journal:  Nat Rev Neurol       Date:  2012-05-08       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.